Profund Advisors’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152K | Sell |
30,176
-7,749
| -20% | -$39.1K | 0.01% | 941 |
|
|
2025
Q1 | $246K | Buy |
37,925
+10,415
| +38% | +$67.5K | 0.01% | 794 |
|
|
2024
Q4 | $202K | Sell |
27,510
-9,954
| -27% | -$73.1K | 0.01% | 1010 |
|
|
2024
Q3 | $281K | Buy |
37,464
+7,336
| +24% | +$54.9K | 0.01% | 842 |
|
|
2024
Q2 | $268K | Sell |
30,128
-40,998
| -58% | -$365K | 0.01% | 787 |
|
|
2024
Q1 | $721K | Buy |
71,126
+2,343
| +3% | +$23.7K | 0.03% | 452 |
|
|
2023
Q4 | $692K | Sell |
68,783
-22,255
| -24% | -$224K | 0.03% | 417 |
|
|
2023
Q3 | $853K | Buy |
91,038
+31,029
| +52% | +$291K | 0.05% | 319 |
|
|
2023
Q2 | $1.47M | Buy |
60,009
+910
| +2% | +$22.3K | 0.08% | 214 |
|
|
2023
Q1 | $1.38M | Buy |
59,099
+45,932
| +349% | +$1.07M | 0.09% | 203 |
|
|
2022
Q4 | $333K | Sell |
13,167
-245
| -2% | -$6.2K | 0.02% | 583 |
|
|
2022
Q3 | $259K | Sell |
13,412
-83
| -0.6% | -$1.6K | 0.02% | 661 |
|
|
2022
Q2 | $344K | Buy |
13,495
+2,584
| +24% | +$65.9K | 0.02% | 559 |
|
|
2022
Q1 | $281K | Sell |
10,911
-1,196
| -10% | -$30.8K | 0.01% | 992 |
|
|
2021
Q4 | $507K | Sell |
12,107
-1,513
| -11% | -$63.4K | 0.02% | 604 |
|
|
2021
Q3 | $593K | Buy |
13,620
+537
| +4% | +$23.4K | 0.02% | 549 |
|
|
2021
Q2 | $619K | Sell |
13,083
-43
| -0.3% | -$2.03K | 0.02% | 548 |
|
|
2021
Q1 | $673K | Sell |
13,126
-1,253
| -9% | -$64.2K | 0.03% | 442 |
|
|
2020
Q4 | $385K | Buy |
14,379
+1,377
| +11% | +$36.9K | 0.02% | 675 |
|
|
2020
Q3 | $446K | Buy |
+13,002
| New | +$446K | 0.02% | 490 |
|